THE IMPACT OF SOME FACTORS ON OOCYTE MATURATION IN PATIENTS UNDERGOING IN VITRO FERTILIZATION AT HANOI MEDICAL UNIVERSITY HOSPITAL
Nội dung chính của bài viết
Tóm tắt
Objective: To characterize oocyte maturation status and investigate clinical factors influencing oocyte maturity in controlled ovarian stimulation cycles for in vitro fertilization (IVF).
Materials and Methods: This retrospective descriptive study analyzed 139 IVF cycles utilizing a GnRH antagonist protocol at the Center of IVF and Tissue Engineering, Hanoi Medical University Hospital, between January 2023 and June 2024. Data regarding oocyte developmental stage, ovarian stimulation parameters, and fertilization outcomes were systematically collected and evaluated.
Results: Mature oocytes at the metaphase II (MII) stage constituted 65.81 ± 17.92% of the total oocytes retrieved, whereas immature oocytes at the metaphase I (MI) and germinal vesicle (GV) stages accounted for 9.2 ± 11.18% and 6.88 ± 10.55%, respectively. The intracytoplasmic sperm injection (ICSI) rate was 69.36 ± 17.64%, with a corresponding fertilization rate of 88.29 ± 18.03%. Prolonged duration of infertility and lower initial doses of recombinant FSH were significantly associated with an increased proportion of immature oocytes (p = 0,001 and p = 0,022, respectively). In contrast, a longer duration of ovarian stimulation was positively correlated with higher oocyte maturation rates (p = 0,031). No statistically significant associations were observed between oocyte maturity and patient age, anti-Müllerian hormone (AMH) levels, body mass index (BMI), or serum concentrations of LH, estradiol, and progesterone at the time of trigger.
Conclusion: The degree of oocyte maturation in IVF cycles appears to be influenced by modifiable clinical variables, particularly the duration of infertility, the initial FSH dosage, and the length of ovarian stimulation. Further large-scale studies are needed to elucidate the role of these factors in optimizing oocyte quality and enhancing clinical outcomes.
Chi tiết bài viết
Từ khóa
Oocyte, oocyte maturation, in vitro fertilization (IVF).
Tài liệu tham khảo
[2] Borges E, Zanetti BF, Setti AS, et al. FSH dose to stimulate different patient ages: when less is more. JBRA Assist Reprod 2017; 21: 336–342.
[3] Nicholas C, Darmon S, Patrizio P, et al. Changes in the clinical significance of oocyte maturity grades with advancing female age advance precision medicine in IVF. iScience 2023; 26: 107308.
[4] Nguyen Viet Tien, Nguyen Thi Ngoc Phuong. Expert Consensus on the Evaluation and Classification of Oocytes and Embryos in Assisted Reproductive Technology (ART). Vietnam Association of Gynecology and Obstetrics – Family Planning (VINAGOFPA), Vietnam Society for Reproductive Medicine (VSRM). 2012.
[5] Can DT, Ha NH. Outcomes of In Vitro Fertilization (IVF) at Vinh Phuc Obstetrics and Pediatrics Hospital from 2020 to 2023. Vietnam Med J; 540. Epub ahead of print 14 July 2024.
[6] Lee HJ, Jee BC, Suh CS, et al. Oocyte Maturity in Relation to Women’s Age in In Vitro Fertilization Cycles Stimulated by a Single Regimen. Yonsei Med J 2012; 53: 181–185.
[7] Sarkar P, Ying L, Plosker S, et al. Duration of ovarian stimulation is predictive of in vitro fertilization outcomes. Minerva Ginecol 2019; 71: 419–426.
[8] Chuang M, Zapantis A, Taylor M, et al. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet 2010; 27: 711–717.
[9] Liu M, Wang C, He L, et al. Effect of different starting doses of FSH on laboratory and clinical outcomes in patients with moderate AMH levels. Horm Athens Greece 2024; 23: 331–338.
[10] Kalinowska V, Hughes L, Lawson AK, et al. Higher Luteinizing Hormone (LH) Levels on the Day of Trigger Are Associated with Lower Oocyte Maturation in Women Undergoing Planned Oocyte Cryopreservation—Fertil Steril 2024; 122: e228.